The burden of migraine to society and to the individual is well documented, so why does it continue to be underestimated by patients and doctors alike? In this podcast, Doctor Susan Tomlinson describe how to adequately assess the impact of migraine and incorporate shared decision making into the treatment plan. She also discusses the role of the CGRP inhibitors in migraine prophylaxis and shares her tips on their use.
This article was commissioned by Eli Lilly Australia Pty Ltd. The content is independent and based on studies and the author’s opinion. The views expressed do not necessarily reflect the views of Eli Lilly. Before prescribing please review the full product information for Emgality via the TGA website. Treatment decisions based on these data are the responsibility of the prescribing physician.